29th Annual Pharmacological Conference for Advanced Practice Providers: Pediatrics Enduring Module

Course ID: 24CE00122
September 6, 2024
Enduring Material

Paid 3.0 ANCC 3.0 Pharmacotherapeutic 3.0 AAPA

Registration Starts on September 6, 2024

Pediatrics Enduring Module

Course ID: 24CE00122

The estimated time to complete this activity is 180 minutes.

Kenton R. Amstutz, DO, FAAP

Nothing to disclose

Objectives:

Select appropriate ADHD medications based on pharmacodynamic profiles, considering factors such as patient age, symptomatology, and medical history.
Utilize systematic monitoring and adjustment protocols to optimize medication efficacy and minimize side effects in pediatric patients with ADHD.
Discuss best practices for prescribing ADHD medications, including informed consent, titration strategies, and long-term management considerations.

Christopher Shaffer, PharmD, PhD, MS

Nothing to disclose

Objectives:

Describe the impact of ontogeny on drug metabolism and efficacy in pediatric patients.
Discuss the role of pharmacogenomics in pediatric pharmacotherapy to optimize treatment outcomes and minimize adverse reactions.

Ken Zoucha, MD

Nothing to disclose

Objectives:

Discuss the epidemiology of substance use disorders in Nebraska with emphasis on adolescents and young adults.
Identify medications and their underlying mechanisms of actions utilized in the treatment of substance use disorders.
Examine the barriers hindering the effective utilization of medications for the management of substance use disorders.

				In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The University of Nebraska Medical Center designates this activity for 3.0 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity. 3.0 contact hours are related to pharmacotherapeutic content.
				University of Nebraska Medical Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.